Our company exists to transform mental health care and that starts with transforming the experience of those who are suffering.
Our commitment to patients
Patient need drives everything we do. Our patient charter sets out our commitment to bringing innovation to patients as quickly as possible, in a way that prioritises patient safety, inclusion, transparency, and access.
Our patient charter
We will report on our progress towards achieving these commitments every year, and update them to reflect patient needs, as we work to bring psilocybin therapy to everyone who might benefit from it.
We are committed to keeping patients safe at every step of their therapeutic journey. We will work to achieve this by developing therapies that have been tested rigorously for their safety and efficacy in large-scale clinical trials, and by recruiting capable and compassionate therapists who are motivated to help patients, and training them to always prioritise patient wellbeing and care.
We will establish a series of independent patient panels, made up of patients and their caregivers, and representing a range of experiences, demographics, and geographies. We commit to seeking patient input as we develop innovations in mental health care – so that our actions are informed by patient voices.
Once published in a peer-reviewed journal, we will ensure open access to our research findings, making it available for everyone to read free of charge. We are committed to sharing the results of this research on our website, in plain language, in a timely and accessible manner, so that patients can understand it.
We are committed to developing evidence-based innovations, whilst developing access and pricing strategies that prioritise affordability and accessibility. We are working closely with payors, patient advocacy groups, healthcare systems and regulators to understand how we make our therapies available to everyone who might benefit from them.
Learn more about the work we are doing to understand and meet patient needs
Marginalised and underprivileged communities
In 2020 COMPASS provided an unrestricted educational grant to the Emory University/Grady Trauma Project in Atlanta.
Understanding patient perspectives
We work with the DBSA to better understand the lived experience of people with depression.
Making psilocybin therapy as affordable and accessible as possible
Our priority is, and will always be, to help patients, and so we will price our COMP360 psilocybin therapy responsibly, with the goal of making it as affordable and accessible as possible.
Psychological support is an integral part of a patient’s psilocybin therapy. We are committed to training and working with therapists to shape how that support is delivered.
Our commitment to therapists
Our therapist charter outlines our commitment to help therapists deepen their knowledge, support their wellbeing, champion professional recognition, and develop a diverse and inclusive community.
Our therapist charter
We will report on our progress towards achieving these commitments every year, and update them to reflect the needs of therapists working with us and the patients they support.
We are committed to providing ongoing opportunities for therapists who take part in our training, to deepen their knowledge and capabilities, so they can support and help patients to generate insights that relieve their suffering. We will provide resources and education through our “Shared Knowledge” interactive therapist training platform and our regular webinar series, and enhance our mentorship programme so that every therapist has an opportunity to learn from the experience and knowledge of other therapists.
We are committed to working with academics and experts in the field to establish standards and a certification process for COMP360 psilocybin therapists in Europe and North America.
Therapist wellbeing is a foundation for ensuring maximum patient benefit. We are committed to supporting our therapists with strategies for self-care. We encourage an environment of support and openness, where therapists can talk to us and each other about their wellbeing.
We are committed to recruiting therapists from different ethnicities, cultures, backgrounds, experiences, and social groups. We will engage with a diverse community of therapists so that our work is inclusive of different needs. We will ensure, where possible, that therapists admitted to the training programme reflect the communities where they practise (including race, gender, and identity).
Learn more about how we work with therapists
Our Therapist Charter
Psychologist Elizabeth Nielson collaborated on our Therapist Charter and talks about why it is important.
A carefully designed training programme
Our therapist training programme has been designed by leading experts from the fields of psychology, psychiatry and psychedelic therapy research.
Frontiers in Psychiatry
Summary of a paper published in Frontiers in Psychiatry on 3 February 2021 “Development and Evaluation of a Therapist Training Programme for Psilocybin Therapy for Treatment-Resistant Depression in Clinical Research”